Genelux (GNLX) Common Equity (2022 - 2026)

Genelux has reported Common Equity for 5 years, with the latest figure at $22.9 million in Q1 2026.

• On a quarterly basis, Common Equity fell 23.2% year-over-year to $22.9 million in Q1 2026; TTM through Mar 2026 was $22.9 million, a 23.2% decrease from a year earlier, with the FY2025 full-year figure at $11.5 million, down 56.06% from the prior year.
• Common Equity was $22.9 million for Q1 2026 at Genelux, up from $11.5 million in the prior quarter.
• The five-year high for Common Equity was $200.0 million in Q1 2023, with the low at -$32.3 million in Q3 2022.
• Average Common Equity over 5 years is $47.0 million, with a median of $24.0 million recorded in 2023.
• The sharpest annual moves came in 2023 and 2024: Common Equity soared 174.32% in 2023, then plunged 92.46% in 2024.
• Over 5 years, Common Equity stood at $75.0 million in 2022, then plunged by 74.04% to $19.5 million in 2023, then surged by 34.93% to $26.3 million in 2024, then plunged by 56.06% to $11.5 million in 2025, then jumped by 98.55% to $22.9 million in 2026.
• The last three Common Equity figures came in at $22.9 million (Q1 2026), $11.5 million (Q4 2025), and $18.6 million (Q3 2025), per Business Quant data.